Steven Agafonoff
Plastic and Reconstructive Surgery · Los Angeles, CANPI 1811347511
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (42.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by OVIK Health, LLC at 46.2% of the total. Reporting peaked in 2022 at $10,374 and has fallen 87.6% since, to $1,285 in 2025.
Across 60 payments — averaging $241.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- OVIK Health, LLC$7K
- Smith+Nephew$4K
- Trimed, Inc.$933
- Axogen$695
- Integra Lifesciences Corporation$431
- Sanara Medtech Inc.$425
- plus $2K from 12 others
What the payments were for
- Consulting fees$2,43517%
- Speaking & faculty fees$1,50010%
- Travel & lodging$6,08542%
- Food & beverage$4,44431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| OVIK Health, LLC | 5 | $6,686 |
| Smith+Nephew | 19 | $3,614 |
| Trimed, Inc. | 2 | $933 |
| Axogen | 4 | $695 |
| Integra Lifesciences Corporation | 4 | $431 |
| Sanara Medtech Inc. | 5 | $425 |
| Avita Medical Americas, LLC | 4 | $406 |
| Access Pro Medical, LLC | 3 | $260 |
| Davol Inc. | 2 | $256 |
| AbbVie(2 entities) | 2 | $181 |
| Progenacare Global, LLC | 3 | $132 |
| Organogenesis Inc. | 1 | $125 |
| Leica Microsystems Inc. | 1 | $118 |
| Kerecis Limited | 1 | $108 |
| Medtronic | 1 | $35 |
| Medline Industries LP | 1 | $26 |
| Baxter Healthcare | 1 | $20 |
| Acelrx Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ASSIST SILVER$6,686
- PERMEADERM$6,686
- COLLAGENASE SANTYL$1,479
- PICO$1,406
- INTEGRA$1,244
- Oasis$952
- Tools - WFS$933
- VERSAJET II$689
- Renasys$689
- Grafix$689
- AVANCE NERVE GRAFT$645
- AxoGuard Nerve Connector$645
- AxoGuard Nerve Protector$645
- INTEGRA DERMAL REGENERATION TEMPLATE$415
- PRIMATRIX$415
- GRAFIX PL$359
- CellerateRx$338
- Kerecis Omega3 Marigen$325
- RECELL$265
- Matriderm$238
How this compares
$14,464 in reported general payments places this provider in the 85th percentile of 349 plastic and reconstructive surgery providers in California.
See all plastic and reconstructive surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic and reconstructive surgery in Los Angeles
- David KulberLos Angeles$194K
- Jeffrey HammoudehLos Angeles$159K
- Justine LeeLos Angeles$13K
- Dan YaminiLos Angeles$11K
- Reza JarrahyLos Angeles$10K
- Nicholas DoLos Angeles$10K
- Mark SuskiThousand Oaks$294K
- Corey MaasSan Francisco$286K
- Arian MowlaviLaguna Beach$250K
- Charles LeeSan Francisco$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.